Contracts Finder

NHS National Framework for Transition products commencing 1 May 2024

NHS England

Awarded
goods
SME-friendly
Framework agreement

Published on NHS Health Family Atamis procurement portal

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.

Key details

Contracting authority
NHS England
nhs
Region
Runcorn, Cheshire,
Sector
Healthcare & Medical
Contract value
£7,559,000ex VAT
Submissions closed
18 March 2024
Published
16 February 2024

Procurement

Contract period
1 May 2024 - 30 September 2025
1 years
Procedure type
Open procedure (above threshold)
CPV classifications
  • 33600000 Pharmaceutical products

What happened

NHS England awarded this contract to Teva UK Limited | Kent Pharma Ltd | Celix Pharma Ltd. | Dr.Reddy's Laboratories (UK) Limited | Thornton and Ross Ltd | Glenmark Pharmaceuticals Europe Limited | Mylan | Selective Supplies Ltd. | Sandoz Ltd | LogixX Pharma Ltd | Immedica Pharma AB | Aspire Pharma Limited worth £7,559,000 on 16 Apr 2024. The contract runs until 30 Sept 2025.

Description

Project title: NHS National Framework for Transition products commencing 1 May 2024 Offer reference number: CM/TNS/05/2024

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:

CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months) Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)

CM/TNS/05/2024/02 - Apixaban, Sapropterin Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Awarded suppliers (12)

Suppliers
  • Teva UK Limited
  • Kent Pharma Ltd
  • Celix Pharma Ltd.
  • Dr.Reddy's Laboratories (UK) Limited
  • Thornton and Ross Ltd
  • Glenmark Pharmaceuticals Europe Limited
  • Mylan
  • Selective Supplies Ltd.
  • Sandoz Ltd
  • LogixX Pharma Ltd
  • Immedica Pharma AB
  • Aspire Pharma Limited
Award value
£7,559,000
Award date
16 April 2024

Contact

Address
NHS England, Runcorn, Cheshire, WA7 2ES
Contact name
Katie Noonan
Email
[email protected]

Identifiers

Buyer reference
CF-2305300D0O000000rwimUAA
Notice ID
414715d8-13f0-43f1-b262-2414d1189130-743806
OCID
ocds-b5fd17-c543315b-95e4-4921-9db4-3e85671128a1

Explore related tenders

Other tenders from NHS England

View all →
Secondary Care Medicines Data Pre-Market Engagement£6,750,000
Targeted Prostate Cancer Screening Programme - MRI Reporting Service
Quality Assurance & Improvement of Structured Learning Placement (SLP) Modules£98,000
Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service
Strengthening Cultural Capability and Trauma Informed Care in Women’s Health£175,000

External ID: cf-ocds-b5fd17-c543315b-95e4-4921-9db4-3e85671128a1 • Added 3 October 2026